Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
about
Fluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsGenetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunitiesA Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling.Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.Evaluation of Renal Function in Alzheimer's Disease and Geriatric Patients: Results from a Turkish Two-center Study.Before it is too late: professional responsibilities in late-onset Alzheimer's research and pre-symptomatic prediction.A consensus in Korea regarding a protocol to reduce preanalytical sources of variability in the measurement of the cerebrospinal fluid biomarkers of Alzheimer's disease.Proteome-wide characterization of signalling interactions in the hippocampal CA4/DG subfield of patients with Alzheimer's disease.A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status.Weak cation exchange magnetic beads coupled with matrix-assisted laser desorption ionization-time of flight-mass spectrometry in screening serum protein markers in osteopenia.Oral glucose tolerance testing to modulate plasma amyloid levels: A novel biomarkerThe Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target PopulationsLongitudinal changes in microstructural white matter metrics in Alzheimer's disease.Multiple genetic imaging study of the association between cholesterol metabolism and brain functional alterations in individuals with risk factors for Alzheimer's disease.Multimodal Brain Imaging Reveals Structural Differences in Alzheimer's Disease Polygenic Risk Carriers: A Study in Healthy Young Adults.PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders,Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies.Catecholamine-Based Treatment in AD Patients: Expectations and Delusions.How many biomarkers to discriminate neurodegenerative dementia?Risk Stratification Using Cerebrospinal Fluid Biomarkers in Patients with Mild Cognitive Impairment: An Exploratory Analysis.Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid.Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.Discovery of Novel Biomarkers for Alzheimer's Disease from Blood.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Computational study on donor-acceptor optical markers for Alzheimer's disease: a game of charge transfer and electron delocalization.Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment: a critical review.Evolving Relevance of Neuroproteomics in Alzheimer's Disease.Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology.[Novel methods for dementia diagnostics].[Clinically validated molecular biomarkers of neurodegenerative dementia].Using Cerebrospinal Fluid Biomarker Testing to Target Treatment to Patients with Mild Cognitive Impairment: A Cost-Effectiveness Analysis.Role of EEG as biomarker in the early detection and classification of dementia.Alzheimer's disease drug development pipeline: 2018.Combining EEG signal processing with supervised methods for Alzheimer's patients classification.fMRI in Neurodegenerative Diseases: From Scientific Insights to Clinical Applications
P2860
Q26784569-65490685-5A74-46AE-B7BE-F32C80AFFB28Q28086879-9EA9A0D6-B4FC-438A-9DA3-4B960B679228Q30235315-AE0512DE-8B45-4E08-874F-8E0BE64519C2Q30996727-08C3E5AD-C528-454B-A2D1-5A972061C28BQ33801119-901A19FA-31E9-41CC-ABE6-B7A380B8F73CQ34547074-BAEDA473-04BE-445C-B260-67264142DEABQ35291150-499E9B53-3BB1-4F3F-BACA-AC2B38BF360EQ35713134-82C711B2-6BC2-4EFE-8A1B-FB8DBC20702CQ36032418-63CCECE4-E66C-4569-9B30-89A3426E5E48Q36062140-6A77A7A9-CC42-4D1E-AAAE-9160D25CD265Q36082829-70752972-0F1E-41DE-B0C7-9AF70C23EDAAQ36165011-A3E7A307-5C49-4842-B5A6-38E82F582E8FQ36244104-A509A144-8A6D-493C-9A05-C7D664EE32E9Q37085773-BB97B7A1-DE48-4BFC-8288-3EFEA60890E4Q37525720-5DB09D33-A35E-4A91-82E7-9F89A30E8384Q37718557-DA08E31F-19EB-4201-AD97-5728AC35B231Q38243166-96C74428-0A4F-4A71-8CD3-391EC69AF136Q38344088-6B52761D-FF86-46D9-A3B5-17B1F40AB427Q38497202-797EC1B2-0CAC-4411-BE94-404C025BEDAAQ38570242-766FE1F4-BB9F-4EA0-A161-BD5BA90A4C54Q38960660-E0AA7BD9-B860-4B79-93FE-61A796C2AB2AQ39181900-7EAE0435-769E-4032-A22B-657E1C4B3AD2Q40809749-9EFFE294-40A5-418A-BB41-55CB24682C80Q42433419-47AA4E8B-FE40-41A4-8534-A21FFAE0BBF0Q47587631-A50B53A1-58E2-42A7-B981-9B6CFAB4EA11Q48946361-F6095E56-1859-4702-8D35-1FC9D841D51DQ49843041-A5241244-F62F-4BCB-8D07-4FBB8E62072FQ50999408-C109392D-F741-4747-8D76-B199793463C2Q51760905-4DE33DA3-8D1F-4A59-AEE5-101F500F1643Q53019881-8EDB44E8-E132-44B4-80F2-AF8B3B66986FQ53357937-D577AFCE-5FE7-435F-BA4B-B3409697F03CQ53416948-F61DB25F-6B4E-44C6-B252-A4ADA2775F0DQ53480784-7E353B8E-E7A8-4940-B28C-28175F61C046Q55357444-9764667E-AC68-4AD9-A683-C0127AFFE533Q55399785-3B08A615-A20F-4939-9C61-51960BD0858EQ57911678-738F4A6E-FC2E-4E53-87B9-6EC088456CD9
P2860
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Perspective on future role of ...... nge point of view beyond 2020.
@en
type
label
Perspective on future role of ...... nge point of view beyond 2020.
@en
prefLabel
Perspective on future role of ...... nge point of view beyond 2020.
@en
P2093
P50
P1476
Perspective on future role of ...... nge point of view beyond 2020.
@en
P2093
Charles Duyckaerts
Francesco Garaci
Hovagim Bakardjian
Karl Broich
Lars Bertram
Olivier Colliot
Robert Nisticò
Simone Lista
Stéphane Epelbaum
Stéphane Lehéricy
P304
P356
10.1016/J.BCP.2013.11.009
P407
P50
P577
2013-11-22T00:00:00Z